Clinical Trial: A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes

U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918625) titled 'A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes' on Oct. 30.

Brief Summary: To evaluate the efficacy of BGM1812 injection compared with placebo in reducing body weight in overweight or obese participants without diabetes after 26 weeks of treatment.

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Overweight or Obese Participants Without Diabetes

Intervention: DRUG: BGM1812 injection / plcaebo

Once weekly or once every two weeks, administered continuously for 24 weeks.

DRUG: BGM1812 injection / plcaebo

Once weekly or once every two weeks, admini...